Oral Mucositis Market Share, Demand, Trends, Analysis and Forecast Report 2023-2030

Oral Mucositis Market Overview
The inflammation and ulceration of the mucosal membranes in the mouth and throat is known as oral mucositis (OM). For patients undergoing radiation and chemotherapy for head and neck cancer, it is a frequent adverse effect and a major problem. Oral mucositis occurs in about 40% of chemotherapy and radiation patients. Unbearable pain and inflammation, a higher risk of infections, malnourishment, dehydration, trouble speaking, and a rise in drug use are examples of serious problems associated with OM.

These lesions might become life-threatening illnesses if left untreated. Fungal testing and biopsy are two of the techniques used to detect oral mucositis. Among the products used to treat OM are antiseptic mouth rinses, pain relievers, bland rinses, water-soluble lubricants, and mucosal coating agents.

Oral Mucositis Market Size and Growth Analysis
The global Oral Mucositis Market is expected to exhibit a CAGR of 5.6% during the forecast period 2023-2030.

Download a Free PDF Sample - https://www.datamintelligence.com/download-sample/oral-mucositis-market

Oral Mucositis Market Dynamics
About 150,000 cases of HNC occur annually in the United States and Europe, compared to 750,000 occurrences worldwide. Of these patients, 60-70% will experience severe oral mucositis (SOM). Oral mucositis is caused by the adverse effects of radiation therapy and cytotoxic chemotherapy drugs on the oral mucosa.

According to estimates from the National Institutes of Health, more than 400,000 Americans receive a diagnosis of oral mucositis each year. Oral mucositis therapies are seeing growth in the market due to the rising global prevalence of cancer patients. As a result, the need for treatments for oral mucositis is expanding quickly, which is anticipated to propel market expansion over the projected period.

For more detailed information - https://www.datamintelligence.com/research-report/oral-mucositis-market

Oral Mucositis Market Segmentation Analysis

By Cause
By Treatment
By End-Users
By Region

Major Companies Covered
EUSA Pharma Inc., Daewoong Pharmaceutical C, Soligenix Inc, Sunstar Suisse VOTRE, Swedish Orphan Biovitrum Ltd., Bausch Health, EKR Therapeutics, Inc, and Access Pharmaceuticals are one of the key players adding to the expansion of the marketplace.

Trending Report
Graft Versus Host Disease Treatment Market: https://www.datamintelligence.com/research-report/graft-versus-host-disease-treatment-market

Osteonecrosis Treatment Market: https://www.datamintelligence.com/research-report/osteonecrosis-treatment-market

Nonalcoholic Fatty Liver Disease (NAFLD) Market: https://www.datamintelligence.com/research-report/nonalcoholic-fatty-liver-disease-market

Inflammatory Myositis Treatment market: https://www.datamintelligence.com/research-report/inflammatory-myositis-treatment-market

Febrile Neutropenia Treatment Market: https://www.datamintelligence.com/research-report/febrile-neutropenia-treatment-market

Paget's Disease Market: https://www.datamintelligence.com/research-report/pagets-disease-market

Erosive Hand Osteoarthritis Market: https://www.datamintelligence.com/research-report/erosive-hand-osteoarthritis-market

Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence 4market Research LLP Ground floor, DSL Abacus IT Park, Industrial Development Area, Uppal, Hyderabad, Telangana 500039

About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.